Deciding whether to handle IT support for your small business in-house or outsource to an external IT team is a difficult decision for any growing business.

From proactively handling cybersecurity issues to managing your VoIP systems, making the right choice for your business IT solutions can be the difference between smooth operations and difficulty keeping up as your business needs change.

We look at the key differences in outsourced IT support vs in-house IT to help you make the correct choice for your business.

What is Outsourced IT Support?

Outsourced IT support

is where an independent company handles all, or part of, your IT infrastructure as an external specialist. These managed IT services can include anything from threat detection and monitoring to supporting you in upgrading your IT infrastructure or migrating to the cloud.

What is an In-House IT Team?

In-house IT teams handle all of your IT requirements as salaried employees, working exclusively for your company. Depending on the size of your organisation and the specific requirements for your IT infrastructure, in-house IT at a small business could be one person or several people.

Outsourced IT vs In-House IT

Cost

When looking at IT cost comparison, the primary cost of in-house IT services is the salary of the employee that manages your IT systems. Additional costs may apply for extra training. In contrast, outsourced IT is a consistent monthly fee.

Expertise & Skillset

An in-house IT professional will usually need to be a ‘jack-of-all-trades’, handling every aspect of your IT solo. This includes anything from troubleshooting and problem-solving to system upgrades and cybersecurity measures. Outsourced IT companies provide you with access to multiple specialised professionals to seamlessly handle your IT.

Scalability

One of the most significant IT outsourcing benefits is easy scalability. Instead of going through a hiring process for a new IT team member, required to scale up in-house IT, you can simply increase your support as and when needed to ensure continuity of service.

Availability & Support

Managed IT services are often available around-the-clock, including automated monitoring systems that alert the team of any problems for fast resolution. In-house IT is typically only available during normal working hours, unless you hire enough people to provide 24/7 support or require employees to be on-call to fix IT problems at short notice.

Pros and Cons

Outsourced IT Support Pros:

• Access to expert support: An external team typically has experts across all areas of IT, from cloud migration to management of specific hardware and software
• Advanced protection: Managed IT services usually include advanced cybersecurity protection, including firewalls and 24/7 threat detection, to help keep your business safe
• Support for systems: If you want to upgrade your systems, introduce a new cloud telephony solution or source suitable software, an outsourced IT team can provide the expert help you need
• Proactive management: Active monitoring and around-the-clock support means that problems can be resolved proactively, instead of waiting for them to be discovered later on

Outsourced IT Support Cons:

• No physical presence: While engineers will visit your site to resolve issues, IT support is generally remote, with tickets submitted through a helpdesk to get support
• Less direct oversight: Outsourcing services mean you have less direct management of your day-to-day IT operations, which may make you feel out of the loop
• Data security and compliance: When working with an outsourced IT team, it’s important you pick a service that complies with all necessary GDPR and industry-specific regulations to keep data safe

In-House IT Pros:

• Complete control: You get the full view of your IT services and are able to change focus as and when needed to suit your business plans
• Easy-to-access support: An in-house professional is directly available to their colleagues, reducing the admin required to report problems with IT systems
• Strong business understanding: In-house IT teams understand your organisational goals and what is most important, enabling them to prioritise effectively and know how to use obscure or custom-made systems

In-House IT Cons:

• Higher costs: The cost of a salary or multiple salaries for in-house IT can be significant, particularly in combination with training and other company benefits
• Skill gaps: A single IT professional will likely not have in-depth knowledge and may experience skill stagnation if they do not have the time for additional training
• Poor scalability: In-house IT is difficult to scale effectively in comparison to an outsourced contract, particularly where extensive training is required to bring new IT employees up to speed

Which Option is Right for Your Business?

Whether outsourced IT or an internal team is right for your business will depend on your priorities and business goals. For rapidly growing companies, being able to scale effectively makes a managed IT service the better choice. For small organisations that have highly specialised software requirements, an in-house professional may be a better fit.

The Hybrid Approach

Utilising both outsourced IT for a range of services, including cloud telephony and cybersecurity solutions, can be an ideal way to expand upon your in-house IT services without the need to hire new employees. The hybrid approach is a popular choice for many companies, providing the best of both worlds.

Conclusion

If you’re unsure whether outsourced or internal IT is the best fit for your business, looking at the pros and cons of both is an excellent starting point. At Flotek, we specialise in providing managed IT services to SMEs across the UK, with around-the-clock support to increase uptime and advanced cybersecurity protection to keep your company safe. If outsourced IT is the best choice for your business, we’re your ideal partner.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Software Product Development is a comprehensive process of creating software products from an idea to launch. ArcSonic Tech notes that this process includes planning, development, testing, and support.

In the field of digital solutions, this discipline is key to achieving quality and competitiveness. ArcSonic Tech believes that understanding the stages of design helps companies make informed decisions at each step of the product lifecycle.

This article is a complete guide to Software Solution Development. It covers the main phases of development, team roles, tools, best practices, and industry examples. Highlighted by ArcSonic Tech, this overview helps to better understand the processes of creating software solutions for different platforms.

What Is Software Product Development

This is a structured process of creating a digital product. It includes requirements definition, architecture design, coding, testing, release, and support. Tips by ArcSonic Tech help distinguish between software creation as a service and product-oriented development.

Product creation requires collaboration between a development team, designers, business analysts, and managers. Insights by ArcSonic Tech show that effective communication between participants influences the quality of the final solution.

Main Stages of Software Product Development

Let us consider the key stages of Software Product Development. Each of them has its own goals, tasks, and outcomes.

1. Research and Requirements Definition

This is the first step. The team analyzes the market, user needs, and forms technical requirements. ArcSonic Tech experts note that the foundation of the entire project is established at this stage.

Analytics at this stage must be thorough. According to this study, about 60% of projects undergo changes due to a lack of early requirements analysis. This information emphasizes the importance of high-quality research.

2. Architecture Design

After gathering requirements, the team creates the architecture of the solution. This includes data models, component distribution, and technology selection. A well-designed architecture optimizes further design.

Design also involves defining coding standards, project structure, and integrations with other systems.

3. Code Creation

This is the core of the process. Engineers write code according to the requirements and design decisions. This stage takes the most time.

Development involves the use of version control systems, build automation, and standardization. Each code module must be easy to maintain.

4. Testing

Once the functionality is in place, the solutions moves on to testing to check its quality and stability. The team at ArcSonic Tech stresses the importance of thorough testing, covering everything from unit tests to integration tests.

Many projects implement automated testing. It reduces human errors and accelerates releases.

5. Release and Support

After testing, the product is ready for launch. A release is the deployment of ready software. After the release, the team continues to support the solutions. Explained by ArcSonic Tech, support includes bug fixes and updates.

The lifecycle continues even after market launch.

Key Roles in a Product Development Team

In Software Product Development, every role is important. Let us review the main positions.

Product Manager Role

The manager defines the product strategy. This role coordinates requirements, business goals, and team efforts. It is a key role for a successful launch.

Tech Lead Role

The tech lead is responsible for technical decisions. This role oversees architecture, standards, and code quality. It works closely with the team.

Developer Role

Developers write code and implement functionality. They work with programming languages, frameworks, and libraries.

Tester Role

Testers check the solutions for defects. They create tests, verify scenarios, and prepare reports.

DevOps Engineer Role

A DevOps specialist automates release processes. This role configures CI/CD pipelines, servers, and hosting.

Key Approaches to Product Creation

There are different approaches in Software Product Development. According to ArcSonic Tech, the choice depends on the type of product and customer requirements.

Waterfall Model

This is a traditional approach. The stages follow a sequential order. It is suitable for projects with clearly defined requirements.

Agile Approach

An adaptive process with short iterations. Agile allows faster response to changes. ArcSonic Tech notes that many teams today choose this approach.

Scrum

This is a popular Agile methodology. The team works in sprints. There are regular meetings and reviews.

Kanban

A method focused on a continuous flow of tasks. It allows tracking the status of each task on a board.

Tools Used in Product Development

Choosing the right tools is important for productivity. Let us review the main categories.

Version Control Systems

Git is the most widely used system. It allows teams to collaborate on code.

CI/CD Tools

CI/CD systems automate build and testing processes. They accelerate product delivery to production.

IDEs and Editors

Visual Studio Code and IntelliJ IDEA are popular among developers. They support syntax highlighting and extensions.

Project Management Systems

Jira and Trello help track task progress.

Numbers and Trends in Software Development

Market analysis shows significant growth in demand for software products. This report demonstrates that the software development market will grow by more than 8% annually until 2030. This confirms the importance of investing in high-quality development.

Such indicators show that Software Product Development remains one of the most dynamic sectors in IT.

Best Practices in Product Creation

Following practices helps create stable solutions. ArcSonic Tech notes the following approaches:

• Regular retrospectives to improve processes.
• Test automation.
• Requirements documentation.
• User involvement in testing.

These practices reduce risks and improve quality.

Conclusion

Software Product Development is a complex but structured process. It includes research, architecture, coding, testing, release, and support. ArcSonic Tech notes that each stage is important for solutions success. In a team, key roles are played by the product manager, developers, testers, and DevOps specialists.

Modern approaches, such as Agile, allow flexibility at all phases. ArcSonic Tech believes that applying best practices and the right tools contributes to effective development. Thanks to statistical data and market analysis, it is possible to plan resources and expectations.

This guide is a general overview of the Software Product Development topic. Knowledge of processes helps developers and managers create high-quality digital solutions. Tips by ArcSonic Tech help the reader better navigate key stages and approaches.

Axis Bank shares ended at ‘1,324.2 on Monday. The broader benchmark Nifty 50 was up 0.8% at close.

Agencies

Q4 in line with estimates,but West Asia-linked provisions up 56% QoQ

Bloomberg consensus implies an average upside of about 19.5% in the next year, and 94% of analysts covering Axis Bank have a ‘Buy’ rating on the stock, according to Bloomberg data.

“The bank’s results were broadly in line with expectations, with 18% year-on-year loan growth driven primarily by the corporate segment. However, performance was weighed down by elevated provisions linked to the West Asia conflict, which rose sharply, up 56% sequentially and 150% year-on-year, indicating a more cautious stance relative to peers,” said Arijit Malakar, equity research analyst at Ashika Stock Broking.

Among large brokers, Citi, CLSA, HSBC, Jefferies, JP Morgan, Nomura and UBS hiked their targets on the stock post results, while maintaining their positive stance.

Live Events

Brokerage Macquarie maintained its ‘Outperform’ rating on the stock, and retained its price target of ‘1,500.
Amid rising geopolitical uncertainty, management has conservatively reallocated most of the tax benefit to strengthening provisions (’20 bn) on an identified pool of standard assets, leading to higher credit costs despite an improving asset quality, as well as reducing slippages, said Suresh Ganapathy of Macquarie in a note to clients.”Thus, we believe credit cost could decline in the coming quarters if the West Asia conflict subsides and provides further cushion to ROA (Return on Assets),” he said.

The taxman has been forced into a tactical retreat over a contentious VAT levy on free medicines supplied to seriously ill patients, after Britain’s pharmaceutical heavyweights warned the policy was jeopardising the country’s standing as a global life sciences hub.

HM Revenue & Customs has confirmed to the industry that it will pause enforcement of disputed VAT bills issued against drugs companies providing medicines free of charge under early access programmes, while Whitehall thrashes out a longer-term settlement with the sector.

The climbdown follows mounting alarm in boardrooms after Bayer, the German pharmaceutical multinational, took the unprecedented step last month of halting new patient enrolments under its UK compassionate use scheme. *Business Matters* understands that at least one further major drugmaker is now actively weighing a similar withdrawal, raising the spectre of vulnerable patients being denied cutting-edge therapies.

At the heart of the dispute are post-clinical trial continuity of care and compassionate use schemes, arrangements designed to bridge the gap for patients with life-threatening or severely debilitating conditions who require access to medicines that have yet to secure marketing authorisation or NHS funding. For many of these patients, the schemes represent a clinical lifeline.

HMRC had begun issuing VAT demands to pharma companies on the basis that supplying these medicines, even gratis, constituted a taxable transaction. Industry leaders have argued the interpretation is not only commercially punishing but threatens to undermine the UK’s hard-won reputation as a destination of choice for clinical research, a sector ministers have repeatedly identified as central to the government’s growth ambitions.

The Association of the British Pharmaceutical Industry has been pressing ministers to confirm that “clinically justified” free-of-charge supply should fall outside the scope of VAT altogether. Without that assurance, executives warn, multinational sponsors will simply route their next generation of trials to more accommodating jurisdictions.

Following a recent meeting between Treasury officials and pharma chief executives, HMRC policy officials have informed the industry that, while the agency retains an obligation to protect Exchequer revenue, it accepts the government is “actively considering” the issue. The taxman has therefore agreed to exercise its discretion by extending review periods and holding off on enforcement action while talks continue. Crucially, however, HMRC has not budged on its view of historic tax liabilities, meaning bills already issued remain on the table.

A Whitehall source insisted that no blanket reprieve was on offer, with each case being assessed individually. “HMRC is not systemically extending review periods,” the source said.

The political temperature has been rising for months. Julia Lopez, the shadow science, innovation and technology secretary, wrote to Liz Kendall, her opposite number, in February warning that “the UK’s reputation as a home for clinical research is essential to our status as a life sciences superpower. That reputation is now at risk.”

In a reply this month, Lord Vallance, the science minister and a former senior executive at GSK, acknowledged ministers were “aware of the issue” and recognised “the importance of patients across the UK having access to innovative medicines.” He confirmed the government was in “discussions with the sector on this matter” and added: “I fully recognise the concerns you have raised.”

Bayer, in announcing its decision to suspend new enrolments, said it had been supplying treatments to patients with “life-threatening, long-lasting, or severely debilitating conditions or diseases which cannot satisfactorily be treated by any licensed and reimbursed drug in the UK.” Following the change in HMRC’s stance, the company said it had “made the difficult decision to pause the addition of new patients” while continuing to serve those already enrolled.

The Treasury maintains that “in certain circumstances the giving of goods away for free can be outside the scope of VAT,” and that where supply does fall within scope, a relief may apply. A government spokesperson said: “We are in active discussions with the sector. We fully recognise the importance of early access and compassionate use schemes and are fully committed to ensuring patients can continue to benefit from them.” A government source added that there had been no recent changes to UK VAT policy.

Lopez was unconvinced. “Even if HMRC has paused this damaging VAT charge, and it’s still not clear, the harm has already begun,” she said.

For an industry that contributes more than £17bn annually to the British economy and employs tens of thousands in high-skilled research roles, the affair has crystallised wider anxieties about the predictability of the UK tax environment. With the government banking heavily on life sciences as an engine of post-Brexit growth, ministers will be acutely conscious that a swift and unambiguous resolution is now needed — not least to reassure the international boardrooms where the next round of investment decisions is already being weighed.

Amy Ingham

Amy is a newly qualified journalist specialising in business journalism at Business Matters with responsibility for news content for what is now the UK’s largest print and online source of current business news.